[Form 4] The Cigna Group Insider Trading Activity
Rhea-AI Filing Summary
Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of The Cigna Group (CI), reported multiple transactions under a Rule 10b5-1 plan. On 08/15/2025 and 08/18/2025 she executed option exercises and open-market trades: option-related acquisitions of 13,155 and 11,598 shares at exercise prices of $197.35 and $183.4405, additional option exercises of 1,348 and 1,329 shares, and a reported sale of 28,526 shares at $300 on 08/15/2025. Following these transactions her reported beneficial ownership positions changed across reported lines (examples shown: 42,576; 54,174; 25,648; 26,996; 28,325). She also holds 1,419.6518 shares indirectly via the company 401(k) plan. The Form 4 states the trades were effected pursuant to a 10b5-1 plan adopted May 8, 2025, and lists Tyler Gratton as attorney-in-fact who signed the filing on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider executed option exercises and a sizeable sale under a pre-established 10b5-1 plan; transactions are material to insider holdings.
The reported Form 4 shows simultaneous option exercises and an open-market sale on 08/15/2025 with follow-up option-related purchases on 08/18/2025. The sale of 28,526 shares at $300 is the largest single disposition disclosed and meaningfully alters reported direct holdings on the form. The filing explicitly identifies the trades as pursuant to a Rule 10b5-1 plan adopted 05/08/2025, which documents pre-arranged timing and may limit contemporaneous trading interpretation. All figures and dates are taken directly from the filing.
TL;DR: Transactions were executed under a 10b5-1 plan and include option exercises and 401(k) participation; procedural disclosures appear complete.
The Form 4 discloses option exercises at stated exercise prices ($183.4405 and $197.35), purchases reported as resulting from those exercises, and indirect ownership via the 401(k). The filing includes the 10b5-1 adoption date and an attorney-in-fact signature, consistent with standard insider reporting practices. The report lists Jones's corporate title and relationship to the issuer, meeting disclosure requirements shown in the document.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 1,348 | $0.00 | -- |
| Exercise | Employee Stock Option (Right to Buy) | 1,329 | $0.00 | -- |
| Exercise | Common Stock, $.01 Par Value | 1,348 | $183.4405 | $247K |
| Exercise | Common Stock, $.01 Par Value | 1,329 | $197.35 | $262K |
| Exercise | Employee Stock Option (Right to Buy) | 11,598 | $0.00 | -- |
| Exercise | Employee Stock Option (Right to Buy) | 13,155 | $0.00 | -- |
| Exercise | Common Stock, $.01 Par Value | 13,155 | $197.35 | $2.60M |
| Exercise | Common Stock, $.01 Par Value | 11,598 | $183.4405 | $2.13M |
| Sale | Common Stock, $.01 Par Value | 28,526 | $300.00 | $8.56M |
| holding | Common Stock, $.01 Par Value | -- | -- | -- |
Footnotes (1)
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. This option was granted on February 27, 2019. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. This option was granted on February 28, 2018. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
